Drug Res (Stuttg) 2014; 64(3): 113-117
DOI: 10.1055/s-0033-1355364
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Effect of Cyanocobalamin (vitamin B12) in the Induction and Expression of Morphine Tolerance and Dependence in Mice

S. Ghazanfari
1   Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IR. Iran
,
M. Imenshahidi
1   Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IR. Iran
,
L. Etemad
1   Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IR. Iran
,
M. Moshiri
1   Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IR. Iran
,
H. Hosseinzadeh
1   Department of Pharmacodynamy and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, IR. Iran
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 29. Mai 2013

accepted 25. Juli 2013

Publikationsdatum:
08. Oktober 2013 (online)

Abstract

The antinociceptive effect of cyanocobalamin (Vit B12) has been reported in animal models and human studies. Our previous study showed the effect of Vit B12 on morphine tolerance. The dependence and tolerance were induced in male mice using subcutaneous morphine injections, 3 times a day (50, 50 and 75 mg/kg/day) for 3 days. Mice also received Vit B12 (100, 250 and 500 µg/kg), clonidine, memantine and saline intraperitoneally before morphine administration. On fourth day mice received only 7 mg /kg morphine just before tail-flick test. To determine the expression of morphine dependence and tolerance, all compounds were injected once intraperitoneally on the day of experiment. The tolerance was evaluated by the tail-flick test. The effect of Vit B12 and other agents on dependence were evaluated by counting the number of jumps (induced by naloxone 5 mg/kg). Co-administration of Vit B12 (100–500 µg/kg) and morphine in 3 days reduced the development of tolerance to morphine analgesic effect (8.2±0.5 and 7.83±0.5 s. vs. normal saline, 3.57±0.3 s). Repeated administration of Vit B12, also, diminished the reduced naloxane withdrawal signs of naloxone withdrawal test (100–500 µg/kg: 5±1.9 and 1.2±0.8 jumps vs. normal saline 72.6±12.2). However, Vit B12 had no effect on the expression of morphine tolerance and physical dependence. It is concluded that co-administration of Vit B12 and morphine could reduce tolerance to analgesic effect of morphine chronic administration and also reduce its withdrawal symptoms.

 
  • References

  • 1 Thienhaus O, Cole BE. Overview of pain: Classification and concept. In: Weiner RS. (ed.) Pain management: A practical guide for clinicians. 6 ed Washington City: CRC; 2002: 27-36
  • 2 Hosseinzadeh H, Jahanian Z. Effect of Crocus sativus L. (saffron) stigma and its constituents, crocin and safranal, on morphine withdrawal syndrome in mice. Phytother Res 2010; 24: 726-730
  • 3 Hosseinzadeh H, Nourbakhsh M. Effect of Rosmarinus officinalis L. aerial parts extract on morphine withdrawal syndrome in mice. Phytother Res 2003; 17: 938-941
  • 4 Hosseinzadeh H, Ziaee T. Effect of Nepeta glomerulosa Boiss. Aerial parts aqueous extract on morphine withdrawal syndrome in mice. Iranian Journal of Pharmaceutical Sciences (IJPS) 2006; 2: 41-46
  • 5 Hosseinzadeh H, Ramazani M, Ghorbani M. Effect of Zhumeria Majdae Rech. F. & Wendelbo aerial part extracts and fractions on morphine withdrawal syndrom in mice. J Med Plants 2007; 6: 48-60
  • 6 Hosseinzadeh H, Lary P. Effect of Salvia leriifolia leaf extract on morphine dependence in mice. Phytother Res 2000; 14: 384-387
  • 7 Imenshahidi M, Hosseinzadeh H, Es’haghian A. Effect of Ethosuximide on morphine tolorance and dependence in mice. Pharmacologyonline 2007; 2: 287-299
  • 8 Hosseinzadeh H, Imenshahidi M, Hosseini M et al. Effect of linalool on morphine tolerance and dependence in mice. Phytother Res 2012; 26: 1399-1404
  • 9 Magana-Villa MC, Rocha-Gonzalez HI, Fernandez Del Valle-Laisequilla C et al. B-vitamin mixture improves the analgesic effect of diclofenac in patients with osteoarthritis: A double blind study. Drug research 2013;
  • 10 Hosseinzadeh H, Moallem SA, Moshiri M et al. Anti-nociceptive and anti-inflammatory effects of cyanocobalamin (vitamin B12) against acute and chronic pain and inflammation in mice. Arzneimittel-Forschung 2012; 62: 324-329
  • 11 Belozertseva IV, Bespalov A. Effects of NMDA receptor channel blockers, dizocilpine and memantine, on the development of opiate analgesic tolerance induced by repeated morphine exposures or social defeats in mice. Naunyn Schmiedebergs Arch Pharmacol 1998; 358: 270-274
  • 12 Popik P, Kozela E, Danysz W. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Naunyn Schmiedebergs Arch Pharmacol 2000; 361: 425-432
  • 13 Bjørke Monsen AL, Ueland PM. Homocysteine and methylmalonic acid in diagnosis and risk assessment from infancy to adolescence. Am J Clin Nutr 2003; 78: 7-21
  • 14 Sethi N, Robilotti K, Sadan Y. Neurological manifestations Of vitamin B-12 deficiency. The Internet Journal of Nutrition and Wellness 2005; 2: 1-5
  • 15 Amanpreet S, Pattipati SN, Shrinivas KK. Quercetin, a bioflavonoid, reverses development of tolerance and dependence to morphine. Drug Dev Res 2002; 57: 167-172
  • 16 Mayer DJ, Mao J, Holt J et al. Cellular mechanisms of neuropathic pain, morphine tolerance, and their interactions. Proc Natl Acad Sci USA 1999; 96: 7731-7736
  • 17 Liaw WJHS, Wang JJ, Wong CS et al. Cellular mechanism of opioid tolerance. Acta Anaesthesiol Sin 1996; 34: 221-234
  • 18 Mao J, Price DD, Mayer DJ. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions. pain 1995; 62: 259-274
  • 19 Kikuchi M, Kashii S, Honda Y et al. Protective effects of methylcobalamin, a vitamin B12 analog, against glutamate-induced neurotoxicity in retinal cell culture. Invest Ophthalmol Vis Sci 1997; 38: 848-854
  • 20 Moretti R, Torre P, Antonello R et al. Vitamin B12 and folate depletion in cognition. A review Neurology India 2004; 52: 310-318
  • 21 Stumpf DA. The neurology of folate and vitamin B12. Neurology 2003; 60: 353
  • 22 Santhosh-Kumar CR, Hassell KL, Deutsch JC et al. Are neuropsychiatric manifestations of folate, cobalamin and pyridoxine deficiency mediated through imbalances in excitatory sulfur amino acids?. Med Hypotheses 1994; 43: 239-244
  • 23 Maldonado R. Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence. Neurosci Biobehav Rev 1997; 21: 91-104
  • 24 Wang Z, Sadée W. Tolerance to morphine at the μ-opioid receptor differentially induced by cAMP-dependent protein kinase activation and morphine. Eur J Pharmacol 2000; 389: 165-171
  • 25 Martínez PJ, Laorden ML, Cerezo M et al. Characterization of the signal transduction pathways mediating morphine withdrawal-stimulated c-fos expression in hypothalamic nuclei. Eur J Pharmacol 2001; 430: 59-68
  • 26 Hao S, Liu S, Zheng X et al. The role of TNFalpha in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats. Neuropsychopharmacology 2011; 36: 664-676
  • 27 Politis A, Olgiati P, Malitas P et al. Vitamin B12 levels in Alzheimer’s disease: association with clinical features and cytokine production. Journal of Alzheimer’s disease: JAD 2010; 19: 481-488